Georg Evers
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Long-Term Effects of COVID-19
Papers in
- Oncology 16
- Lung Cancer Research Studies 6
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 4
-
- Lung Cancer Treatments and Mutations 7
- Lung Cancer Diagnosis and Treatment 5
- Co-authors
- Arik Bernard Schulze (23 shared papers)Michael Möhr (29 shared papers)L. H. Schmidt (15 shared papers)Wolfgang E. Berdel (14 shared papers)Christoph Schliemann (10 shared papers)Dennis Görlich (10 shared papers)Annalen Bleckmann (16 shared papers)Georg Lenz (16 shared papers)
- Journals
- Cancers (6 papers)Therapeutic Advances in Medical Oncology (2 papers)PLoS ONE (2 papers)Canadian Respiratory Journal (2 papers)Translational Lung Cancer Research (2 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Georg Evers
46 papers receiving 593 citations
Peers
Comparison fields: 5 of 75
- Oncology 163
- Neurology 79
- Hematology 56
- Pulmonary and Respiratory Medicine 144
- Cancer Research 54
Countries citing papers authored by Georg Evers
This map shows the geographic impact of Georg Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Evers more than expected).
Fields of papers citing papers by Georg Evers
This network shows the impact of papers produced by Georg Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Evers. The network helps show where Georg Evers may publish in the future.
Co-authors
The 25 scholars most cited alongside Georg Evers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 64 | |
| 2 | 2019 | 60 | |
| 3 | 2017 | 55 | |
| 4 | 2020 | 43 | |
| 5 | 2021 | 30 | |
| 6 | 2016 | 29 | |
| 7 | 2023 | 28 | |
| 8 | 2019 | 23 | |
| 9 | 2015 | 21 | |
| 10 | 2024 | 17 | |
| 11 | Normal values of immunoglobulins in premature and in full-term infants, calculated as percentiles. | 1975 | 16 |
| 12 | 2022 | 15 | |
| 13 | 2020 | 15 | |
| 14 | 2020 | 14 | |
| 15 | 2019 | 13 | |
| 16 | 2014 | 13 | |
| 17 | 2013 | 12 | |
| 18 | 2023 | 11 | |
| 19 | 2022 | 9 | |
| 20 | 2008 | 9 |
About Georg Evers
Georg Evers is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hematology, Molecular Biology and Neurology, having authored 54 papers that have together received 609 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (5 papers), CAR-T cell therapy research (4 papers), Long-Term Effects of COVID-19 (4 papers) and Hematopoietic Stem Cell Transplantation (3 papers). The work is most often cited by research in Oncology (163 citations), Neurology (79 citations), Hematology (56 citations), Pulmonary and Respiratory Medicine (144 citations) and Cancer Research (54 citations). Georg Evers has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Arik Bernard Schulze, Michael Möhr, L. H. Schmidt, Wolfgang E. Berdel, Christoph Schliemann, Dennis Görlich, Annalen Bleckmann, Georg Lenz, Ludger Hillejan and Alessandro Marra. Their work appears in journals such as Cancers, Therapeutic Advances in Medical Oncology, PLoS ONE, Canadian Respiratory Journal and Translational Lung Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.